Approximately 1% to 3% of children under 12 months ... births and neonatal deaths. Pfizer filed for Japanese approval of Abrysvo for the prevention of RSV disease in the older adult setting ...

A study today in JAMA Network Open from the University of California, San Francisco (UCSF), shows a high uptake of respiratory syncytial virus (RSV) vaccine and the RSV-preventing monoclonal antibody ...

Respiratory syncytial virus is a common, highly contagious illness that often causes mild upper respiratory symptoms, akin to a cold. In babies, particularly those with tiny airways, RSV can cause the ...

RSV infection that is managed via primary care in children under 5 years of age leads to a substantial burden for families, primary care resources, and society.

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

In the US alone, RSV infections account for approximately 177,000 hospitalisations and 14,000 deaths each year among older adults, according to Pfizer. For children younger than five years old in ...

Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

The U.S. has seen earlier and more intense surges of the flu and RSV this year than is typical, pediatrician Dr. Ryan Fulton notes.

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

Sales of both GSK’s and Pfizer’s vaccines for respiratory syncytial virus dropped significantly in the last three months of 2024, compared the same period one year before. In a earnings report ...

RSV season is in full swing, according to doctors at Children’s Hospital Colorado. Denver7 spoke with a local family that is ...